Latest News & Features
Asia
The Danish pharma giant is expanding its patent defence in India as multiple generics prepare to challenge its blockbuster diabetes and weight-loss drug ahead of 2026 patent expiry. 9 December 2025
Americas
Solicitor General urges the US Supreme Court to hear an appeal in its dispute, arguing that a ruling threatens the future of skinny labelling and the availability of lower-cost generics. 9 December 2025
Europe
The firm has added a disputes specialist with experience in pharma, biotech and manufacturing sectors across multiple jurisdictions. 8 December 2025
Americas
As part of a broader bid to remove obstacles to patents, director Squires clarifies how examiners, applicants and practitioners may handle patent subject matter eligibility rejections. 8 December 2025
Americas
A Finnish wearable fitness gadget company has lost its bid to overturn the invalidation of a key patent, with the US Federal Circuit affirming it is abstract under Alice. 5 December 2025
Asia
The Delhi High Court has denied an injunction against an Indian generic manufacturer, finding credible challenges to the validity of Novo's semaglutide patent—flagging concerns over obviousness, double patenting, and evergreening. 4 December 2025
Americas
The appeals court reversed a jury verdict, finding the antibody-drug conjugate patent lacked adequate written description and enablement support from its priority application. 3 December 2025
Careers
Firm adds ex-DLA Piper litigator, who brings “deep technical experience” and “a proven track record” in complex patent and trade secrets cases. 3 December 2025
Careers
The firm has hired a former chemical engineer with clients in aviation, medical devices, and industrial manufacturing, who also led Kilpatrick’s patent best practices committee. 3 December 2025
Europe
The move could unlock billions in life sciences collaborations and position the UK to rival the US and China. But turning a famously conservative, patient-safety-first institution into a commercially savvy innovation hub will be no small feat. 2 December 2025